We are pleased to see this litigation moving forward, and look forward to significant progress in the coming year.
New York, New York (PRWEB) January 14, 2013
Biomet hip implant lawsuits continue to move forward in the U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. Pretrial matters were addressed during the litigation’s most recent Case Management Conference, held on January 7, 2013. According to a Memorandum issued by the Court on January 9th, the parties are working on a number of orders covering discovery and production of electronically stored information and the protection of confidential and privileged information. The next Status Conference in the Biomet hip replacement litigation is scheduled for February 4, 2013.* (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“We are pleased to see this litigation moving forward, and look forward to significant progress in the coming year,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The firm is offering free legal evaluations to individuals allegedly injured by the Biomet M2a Magnum Hip device.
Biomet Hip Replacement Lawsuits
All of the Biomet hip implant lawsuits pending in the Northern District of Indiana share similar allegations that the metal-on-metal design of the Biomet M2a Magnum Hip Replacement can shed dangerously high levels of metal ions into surrounding tissue and blood stream. Plaintiffs further allege that this phenomenon can cause serious complications, including metallosis and premature failure of the implant.
The U.S. Food & Drug Administration (FDA) is currently reviewing the safety of metal-on-metal hip implants such as the Biomet M2a Magnum Hip Replacement. According to the agency, metal particles shed by such devices can result in an adverse local tissue reaction that causes damage to bone and/or tissue surrounding the implant and joint. There are also some medical case reports of patients in which high levels of metal ions in the bloodstream may have caused other types of symptoms or illnesses elsewhere in the body, including effects on the heart, nervous system, and thyroid gland, according to the FDA.**
Bernstein Liebhard LLP is offering free lawsuit consultations to anyone allegedly injured as a result of the Biomet M2a Magnum Hip Replacement. Individuals who have endured hip implant failures, metallosis, pain, or revision surgery due to one of these devices may be entitled to compensation for their medical care, pain and suffering, and other damages. A wealth of information regarding the potential dangers associated with metal-on-metal hip implants is available on Bernstein Liebhard LLP’s website. For more information about Biomet hip replacement lawsuits, please contact one of our attorneys by calling 877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP